HIV / AIDS
Jan 26, 2023
ICAP collaborated with the Ministry of Health and CDC to assess the frequency and pattern of HIV drug resistance among people living with HIV. A total of 1,400 people were surveyed in 30 health facilities using a cross-sectional survey. The Lesotho Ministry of Health...
Jan 25, 2023
ICAP contributed to South Africa’s National Strategic Plan on HIV/AIDS and sexually-transmitted infections (STIs) and tuberculosis (TB) by providing technical support for the implementation of comprehensive HIV prevention services for men who have sex with men (MSM)....
Jan 24, 2023
ICAP provided intensive technical assistance and logistical support to 192 health facilities in four regions of Côte d’Ivoire and two tertiary care facilities in Abidjan, measurably increasing the uptake and quality of HIV prevention, care, and treatment services....
Jan 23, 2023
The ADAPT Study recruited men who have sex with men (MSM) and transgender women and was designed to identify oral pre-exposure prophylaxis (PrEP) pill-taking schedules that participants are more likely to follow and determine if these schedules influence healthier...
Jan 22, 2023
HPTN 076 was a two-year study that recruited sexually active women age 18 to 45 and evaluated the safety and acceptability of a new injectable HIV prevention medication, Rilpivirine, for use in healthy, HIV-uninfected women. Report Links: Seneviratne HK et al. 2020....
